Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Louis David Rivière"'
Autor:
Benjamin Honton, MD, Antoine Sauguet, MD, Bruno Farah, MD, Stéphane Gellee, MD, Louis David Rivière, MD
Publikováno v:
JACC: Case Reports, Vol 2, Iss 15, Pp 2394-2396 (2020)
We report the case of an extended pseudo-subarachnoid hemorrhage (PSAH) related to contrast intracerebral diffusion from blood-brain barrier breakdown on periprocedural percutaneous coronary intervention right corticofrontal ischemic stroke. PSAH is
Externí odkaz:
https://doaj.org/article/b2f285db25054823a6f411067699e23a
Autor:
Pierre Mattei, Delphine Dghayem, Agnès Dupret-Bories, Jérôme Sarini, Benjamin Vairel, Louis-David Rivière, Sébastien Vergez, Amélie Lusque, Emilien Chabrillac
Publikováno v:
European Journal of Surgical Oncology.
Publikováno v:
JACC: Case Reports, Vol 2, Iss 15, Pp 2394-2396 (2020)
JACC Case Reports
JACC Case Reports
We report the case of an extended pseudo-subarachnoid hemorrhage (PSAH) related to contrast intracerebral diffusion from blood-brain barrier breakdown on periprocedural percutaneous coronary intervention right corticofrontal ischemic stroke. PSAH is
Autor:
Fabrice Bonneville, Louis-David Rivière, Stephan Petersenn, John S Bevan, Aude Houchard, Caroline Sert, Philippe J Caron, Gaal L Van, J Marek, P Nuutila, M Välimäki, C Ajzenberg, F Borson-Chazot, T Brue, P Caron, O Chabre, P Chanson, C Cortet Rudelli, B Delemer, J-M Kuhn, A Tabarin, K Badenhoop, C Berg, S Petersenn, C Schöfl, J Schopohl, S Cannavò, A Colao, L De Marinis, A Stades, A J van der Lely, P Kadıoğlu, J S Bevan, D Flanagan, P Trainer
Publikováno v:
European journal of endocrinology.
Objective Pituitary adenoma MRI T2 signal intensity associates with tumor characteristics including responsiveness to somatostatin analogs (SSAs). These analyses determined whether baseline T2 signal intensity predicts response to primary medical tre
Publikováno v:
Endocrine Abstracts.
Autor:
Antoine Bennet, Louis-David Rivière, Delphine Vezzosi, Philippe Caron, Solange Grunenwald, Frédérique Rimareix
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 25(8)
The first-choice treatment of thyrotropin (TSH)-secreting pituitary adenomas is surgical adenomectomy, with 40-60% of patients cured after surgery. The presence of somatostatin receptors on the adenomatous cells suggests that first-generation somatos